COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Website maintenance The PDA website will be unavailable due to scheduled maintenance between 8:00 and 17:00 BST on Saturday 20th April 2024

Home  »   Latest News   »   PDA responds to the Department of Health and Social Care consultation ‘Hub and spoke dispensing’

PDA responds to the Department of Health and Social Care consultation ‘Hub and spoke dispensing’

The Department of Health and Social Care (DHSC) recently consulted on its proposals for ‘Hub and spoke dispensing.’ This is the second attempt by the DHSC to consult on proposed changes to the Human Medicines Regulations 2012 and The Medicines Act 1968 to facilitate hub and spoke dispensing between parties that belong to separate legal entities.

Tue 28th June 2022 The PDA

The analysis of the responses from the first attempt made in 2016 clearly states that only 28% of responses supported changes to legislation to enable hub and spoke dispensing. The balance of 72% did not support changes or did not answer the question. The PDA, in its 2016 response stated that it could not support the changes as proposed and it made a number of specific recommendations to the DHSC.

The PDA’s submission to this most recent consultation specifically builds on their 2016 response. As the matters previously highlighted in 2016 have yet to be resolved, the PDA’s position remains unchanged and that it cannot support this latest proposal.

This PDA’s response specifically noted:

  • The continued lack of robust evidence to support the proposals.
  • The lack of discursive consultation and engagement with pharmacists.
  • Issues around appropriate levels of support staff working in community pharmacy as highlighted by the Health Education England surveys.
  • The weakness in the current inspection process by the regulator, which does not appear to take a holistic approach to existing hubs and spokes.
  • The potential for reduced competition, leading to a higher cost of medicines.

The PDA recommends that the proposals be referred to and considered in the round by the Competition and Markets Authority.

Read the PDA’s full response here

thumbnail of 000 Response to 2022 Hub and Spoke Consultation FINAL

Read the consultation document here

thumbnail of 001 Consultation Document 2022 Hub and Spoke

The consultation ran from 16 March 2022 to 8 June 2022.

Learn more

 

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)